119 related articles for article (PubMed ID: 31116030)
1. Is routine baseline brain imaging needed for all newly diagnosed non-small-cell lung cancer patients?
Abdel-Rahman O
J Comp Eff Res; 2019 Jun; 8(8):569-575. PubMed ID: 31116030
[No Abstract] [Full Text] [Related]
2. Population-based validation of the National Cancer Comprehensive Network recommendations for baseline imaging workup of cutaneous melanoma.
Abdel-Rahman O
Melanoma Res; 2019 Feb; 29(1):53-58. PubMed ID: 30362976
[TBL] [Abstract][Full Text] [Related]
3. Population-based assessment of the National Comprehensive Cancer Network recommendations for baseline imaging of rectal cancer.
Abdel-Rahman O; Cheung WY
J Comp Eff Res; 2019 Oct; 8(14):1167-1172. PubMed ID: 31638428
[No Abstract] [Full Text] [Related]
4. Population-based validation of the National Cancer Comprehensive Network recommendations for breast cancer staging.
Abdel-Rahman O
Breast Cancer Res Treat; 2018 Nov; 172(1):231-238. PubMed ID: 30022329
[TBL] [Abstract][Full Text] [Related]
5. Population-based validation of the National Comprehensive Cancer Network recommendations for baseline imaging for bladder cancer: a case for routine baseline bone scan?
Abdel-Rahman O
J Comp Eff Res; 2019 Feb; 8(3):157-163. PubMed ID: 30624081
[TBL] [Abstract][Full Text] [Related]
6. Population-based assessment of the national comprehensive cancer network recommendations for baseline imaging of hepatocellular carcinoma.
Abdel-Rahman O; Cheung WY
Med Oncol; 2019 Feb; 36(3):26. PubMed ID: 30707324
[TBL] [Abstract][Full Text] [Related]
7. Screening for brain metastases in patients with stage III non-small-cell lung cancer, magnetic resonance imaging or computed tomography? A prospective study.
Schoenmaekers J; Hofman P; Bootsma G; Westenend M; de Booij M; Schreurs W; Houben R; De Ruysscher D; Dingemans AM; Hendriks LEL
Eur J Cancer; 2019 Jul; 115():88-96. PubMed ID: 31129385
[TBL] [Abstract][Full Text] [Related]
8. Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: a multicenter study.
Li X; Zhang H; Xing L; Ma H; Xie P; Zhang L; Xu X; Yue J; Sun X; Hu X; Chen M; Xu W; Chen L; Yu J
Radiother Oncol; 2012 Feb; 102(2):246-50. PubMed ID: 22100657
[TBL] [Abstract][Full Text] [Related]
9. Incidence of Brain Metastases on Follow-up
Nia ES; Garland LL; Eshghi N; Nia BB; Avery RJ; Kuo PH
J Nucl Med Technol; 2017 Sep; 45(3):193-197. PubMed ID: 28705927
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Yield of Staging Brain MRI in Patients with Newly Diagnosed Non-Small Cell Lung Cancer.
Kim M; Suh CH; Lee SM; Kim HC; Aizer AA; Yanagihara TK; Bai HX; Guenette JP; Huang RY; Kim HS
Radiology; 2020 Nov; 297(2):419-427. PubMed ID: 32840470
[TBL] [Abstract][Full Text] [Related]
11. Early stage non-small cell lung cancer patients need brain imaging regardless of symptoms.
Ando T; Kage H; Saito M; Amano Y; Goto Y; Nakajima J; Nagase T
Int J Clin Oncol; 2018 Aug; 23(4):641-646. PubMed ID: 29484515
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
[TBL] [Abstract][Full Text] [Related]
13. Does initial staging or tumor histology better identify asymptomatic brain metastases in patients with non-small cell lung cancer?
Shi AA; Digumarthy SR; Temel JS; Halpern EF; Kuester LB; Aquino SL
J Thorac Oncol; 2006 Mar; 1(3):205-10. PubMed ID: 17409858
[TBL] [Abstract][Full Text] [Related]
14. Significance of Brain Imaging for Staging in Patients With Clinical Stage T1-2 N0 Non-Small-Cell Lung Cancer on Positron Emission Tomography/Computed Tomography.
Saito G; Kono M; Koyanagi Y; Miyashita K; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura T; Nozue M; Nakamura H
Clin Lung Cancer; 2021 Nov; 22(6):562-569. PubMed ID: 34253472
[TBL] [Abstract][Full Text] [Related]
15. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Ramirez J; Molins L
Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911
[TBL] [Abstract][Full Text] [Related]
16. Detecting extrathoracic metastases in patients with non-small cell lung cancer: Is routine scanning necessary?
Metintas M; Ak G; Akcayir IA; Metintas S; Erginel S; Alatas F; Yildirim H; Kurt E; Ozkan R
Lung Cancer; 2007 Oct; 58(1):59-67. PubMed ID: 17566597
[TBL] [Abstract][Full Text] [Related]
17. Screening for brain metastases in patients with stage III non-small cell lung cancer: Is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain?
Hendriks LE; Bootsma GP; de Ruysscher DK; Scheppers NA; Hofman PA; Brans BT; Dingemans AM
Lung Cancer; 2013 Jun; 80(3):293-7. PubMed ID: 23518381
[TBL] [Abstract][Full Text] [Related]
18. Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer.
Lin JT; Yang XN; Zhong WZ; Liao RQ; Dong S; Nie Q; Weng SX; Fang XJ; Zheng JY; Wu YL
Eur J Cardiothorac Surg; 2016 Nov; 50(5):914-919. PubMed ID: 27113090
[TBL] [Abstract][Full Text] [Related]
19. An exceptional group of non-small cell lung cancer difficult to diagnose: Evaluation of lipid-poor adrenal lesions.
Simsek FS; Arslan M; Dag Y
Bosn J Basic Med Sci; 2019 May; 19(2):195-200. PubMed ID: 30997878
[TBL] [Abstract][Full Text] [Related]
20. The role of integrated positron emission tomography and computed tomography in the assessment of nodal spread in cases with non-small cell lung cancer.
Tasci E; Tezel C; Orki A; Akin O; Falay O; Kutlu CA
Interact Cardiovasc Thorac Surg; 2010 Feb; 10(2):200-3. PubMed ID: 19933240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]